Effect of cyclo-oxygenase inhibitors on Helicobacter pylori susceptibility to metronidazole and clarithromycin.

Gu, Q; Xia, H H-X; Wang, W H; Wang, J D; Wong, W M; Chan, A O O; Yuen, M F; Lam, S K; Cheung, H K-L; Liu, X G; Wong, B C-Y

Gu, Q; Xia, H H-X; Wang, W H; Wang, J D; Wong, W M; Chan, A O O; Yuen, M F; Lam, S K; Cheung, H K-L; Liu, X G; Wong, B C-Y.

Affiliation

Gu Q; Department of Medicine, University of Hong Kong, China.

Aliment Pharmacol Ther ; 20(6): 675-81, 2004 Sep 15.

Article in En | MEDLINE | ID: mdl-15352916

Subject(s)

Anti-Infective Agents/therapeutic use; Clarithromycin/therapeutic use; Cyclooxygenase Inhibitors/therapeutic use; Helicobacter Infections/drug therapy; Helicobacter pylori; Metronidazole/therapeutic use; Pyrazoles/therapeutic use; Sulfonamides/therapeutic use; Anti-Bacterial Agents/therapeutic use; Cells, Cultured; Drug Interactions; Humans

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Pyrazoles / Sulfonamides / Helicobacter pylori / Helicobacter Infections / Cyclooxygenase Inhibitors / Clarithromycin / Metronidazole / Anti-Infective Agents Limits: Humans Language: En Journal: Aliment Pharmacol Ther Journal subject: FARMACOLOGIA / GASTROENTEROLOGIA / TERAPIA POR MEDICAMENTOS Year: 2004 Document type: Article Affiliation country: China Country of publication: United kingdom

Search on Google

Add to My VHL

XML

PubMed Links